本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Psyence Biomedical Ltd

1.76
-0.0500-2.76%
盤後1.770.0100+0.57%19:50 EST
成交量:6.19萬
成交額:11.09萬
市值:328.63萬
市盈率:-0.32
高:1.85
開:1.81
低:1.76
收:1.81
52周最高:62.72
52周最低:1.41
股本:186.72萬
流通股本:185.98萬
量比:0.30
換手率:3.33%
股息:- -
股息率:- -
每股收益(TTM):-5.5651
每股收益(LYR):5.24
淨資產收益率:-74.29%
總資產收益率:-34.44%
市淨率:0.28
市盈率(LYR):0.34

資料載入中...

2024/08/27

SEC問詢函

Form CORRESP - Correspondence
2024/08/20

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2024/07/31

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/07/27

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/05/13

SEC問詢函

Form CORRESP - Correspondence
2024/05/10

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2024/05/09

SEC問詢函

Form CORRESP - Correspondence
2024/05/07

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2024/05/06

SEC問詢函

Form CORRESP - Correspondence
2024/04/18

SEC問詢函

Form CORRESP - Correspondence
2024/04/18

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2024/02/10

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2024/02/05

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/05

超過5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2024/01/31

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/01/23

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2024/01/17

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2023/11/15

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2023/11/13

SEC問詢函

Form CORRESP - Correspondence
2023/11/03

SEC問詢函

Form CORRESP - Correspondence